BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 8 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 8 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 9 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 10 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 10 hours ago Atmus Welcomes Heath Sharp to Board of Directors 12 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 12 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 8 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 8 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 8 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 9 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 10 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 10 hours ago Atmus Welcomes Heath Sharp to Board of Directors 12 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 12 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT
Analysis

Rating downgrade of Lam Research dampens recovery hopes; stock dips 4%

The recovery of Lam Research (LRCX) from last year’s lows had received a boost after the latest earnings report but the momentum faded in recent weeks, hitting investor sentiment. Market watchers have cautioned that the lull in the semiconductor market might continue this year and beyond due to weak demand for memory chips. Citing the […]

June 12, 2019 2 min read

The recovery of Lam Research (LRCX) from last year’s lows had received a boost after the latest earnings report but the momentum faded in recent weeks, hitting investor sentiment. Market watchers have cautioned that the lull in the semiconductor market might continue this year and beyond due to weak demand for memory chips.

Citing the delay in the expected rebound, research firm Evercore Wednesday downgraded Lam’s stock to in-line from outperform and slashed the target price to $195 from $225. The stock slipped about 4% in pre-market trading following the report, after closing the previous session slightly lower. According to the analyst, the memory market is unlikely to recover before the second half of next year.

According to the analyst, the memory market is unlikely to recover before the second half of next year

The semiconductor equipment provider, which has an average rating of outperform, has been a favorite of investors as the general outlook for the stock remains positive. However, the current trend calls for caution when it comes to short-term investment.

Lam Research Q3 revenue down 16%

For its latest fiscal quarter ended March 2019, Lam Research reported a 23% fall in earnings to $3.70 per share on revenues of $2.4 billion, which is down 16% year-over-year. The decline, however, was not as intense as analysts’ had forecast. Then, the management forecast that adjusted earnings will grow about 20% year-over-year in the June quarter supported by strong revenue growth.

Also see: Lam Research Q3 2019 Earnings Conference Call Transcript

ADVERTISEMENT

For the semiconductor industry, 2018 was a grim year when the softening global economy and the impact of the US-China trade war, combined with the cryptocurrency crash, weighed down on the companies. Meanwhile, reflecting the ongoing improvement, the semiconductor index of S&P 500 gained 25% so far this year.

Lam Research shares gained 37% since the beginning of 2019, after slipping to a 16-month low in December last year. In the past twelve months, the stock moved up about 6%. Rival tech firm Applied Materials (AMAT) lost about 3% early Wednesday after the market reacted negatively to the weak outlook for the chip market.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips

ADVERTISEMENT